{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:00:40Z","timestamp":1774123240707,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.amjmed.2006.01.015","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T12:43:19Z","timestamp":1155818599000},"page":"639-646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Pulmonary Adverse Events of Anti-Tumor Necrosis Factor-\u03b1 Antibody Therapy"],"prefix":"10.1016","volume":"119","author":[{"given":"G\u00f6khan M.","family":"Mutlu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece A.","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Bellmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2006.01.015_bib1","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib2","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2006.01.015_bib3","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2006.01.015_bib4","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/gast.2000.18160","article-title":"Tumor necrosis factor","volume":"119","author":"Papadakis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2006.01.015_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/320584a0","article-title":"Cachectin and tumour necrosis factor as two sides of the same biological coin","volume":"320","author":"Beutler","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2006.01.015_bib6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.amjmed.2006.01.015_bib8","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4049\/jimmunol.162.6.3504","article-title":"Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin","volume":"162","author":"Bean","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","article-title":"Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection","volume":"73","author":"Pfeffer","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.amjmed.2006.01.015_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1172\/JCI113381","article-title":"Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils","volume":"81","author":"Atkinson","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2006.01.015_bib11","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.4049\/jimmunol.136.11.4220","article-title":"Stimulation of neutrophils by tumor necrosis factor","volume":"136","author":"Klebanoff","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib12","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.4049\/jimmunol.135.3.2069","article-title":"Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors","volume":"135","author":"Shalaby","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4049\/jimmunol.138.3.765","article-title":"Immune interferon enhances functional properties of human granulocytes","volume":"138","author":"Perussia","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection","volume":"56","author":"Kindler","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.amjmed.2006.01.015_bib15","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.4049\/jimmunol.161.5.2636","article-title":"Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha","volume":"161","author":"Balcewicz-Sablinska","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib16","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.4049\/jimmunol.164.4.2016","article-title":"Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages","volume":"164","author":"Keane","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib17","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1128\/IAI.68.12.6954-6961.2000","article-title":"Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent","volume":"68","author":"Bekker","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.amjmed.2006.01.015_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.amjmed.2006.01.015_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/cimm.1999.1460","article-title":"Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18","volume":"193","author":"Kawakami","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI110489","article-title":"Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes","volume":"69","author":"Schaffner","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2006.01.015_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1172\/JCI108945","article-title":"Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro","volume":"61","author":"Diamond","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2006.01.015_bib22","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4049\/jimmunol.162.3.1633","article-title":"Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis","volume":"162","author":"Mehrad","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib23","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/172.6.1554","article-title":"Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis","volume":"172","author":"Nagai","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amjmed.2006.01.015_bib24","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1128\/IAI.66.12.5999-6003.1998","article-title":"Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus","volume":"66","author":"Roilides","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.amjmed.2006.01.015_bib25","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1128\/iai.62.7.2761-2772.1994","article-title":"Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis","volume":"62","author":"Louie","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.amjmed.2006.01.015_bib26","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4049\/jimmunol.157.5.2155","article-title":"TNF receptors in murine Candida albicans infection","volume":"157","author":"Steinshamn","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib27","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1128\/iai.63.5.1725-1731.1995","article-title":"Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice","volume":"63","author":"Aguirre","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.amjmed.2006.01.015_bib28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.amjmed.2006.01.015_bib29","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","article-title":"Construction and initial characterization of a mouse-human chimeric anti-TNF antibody","volume":"30","author":"Knight","year":"1993","journal-title":"Mol Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.1995.0029","article-title":"Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions","volume":"7","author":"Scallon","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.amjmed.2006.01.015_bib31","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/gast.2001.28702","article-title":"Infliximab induces apoptosis in monocytes from patients with chronic active Crohn\u2019s disease by using a caspase-dependent pathway","volume":"121","author":"Lugering","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2006.01.015_bib32","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4002::AID-IMMU4002>3.0.CO;2-S","article-title":"A role for lymphotoxin beta receptor in host defense against Mycobacterium bovis BCG infection","volume":"29","author":"Lucas","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib33","first-page":"19","article-title":"Infliximab (Remicade) for Crohn\u2019s disease","volume":"41","year":"1999","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.amjmed.2006.01.015_bib34","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/356604a0","article-title":"Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice","volume":"356","author":"Amiri","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2006.01.015_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/344245a0","article-title":"Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis","volume":"344","author":"Piguet","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2006.01.015_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1172\/JCI118029","article-title":"Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis","volume":"96","author":"Miyazaki","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2006.01.015_bib37","first-page":"70","article-title":"Infliximab for refractory sarcoidosis","volume":"18","author":"Baughman","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.amjmed.2006.01.015_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-135-1-200107030-00010","article-title":"Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy","volume":"135","author":"Yee","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","article-title":"Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis","volume":"124","author":"Utz","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2006.01.015_bib40","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F","article-title":"Etanercept combined with conventional treatment in Wegener\u2019s granulomatosis","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2006.01.015_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2249.1990.tb03336.x","article-title":"Enhanced expression of the tumour necrosis factor\/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis","volume":"81","author":"Deguchi","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener\u2019s granulomatosis","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1183\/09031936.94.07030515","article-title":"Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice","volume":"7","author":"Piguet","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2006.01.015_bib44","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.122.3.1093","article-title":"Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition","volume":"122","author":"Vassallo","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2006.01.015_bib45","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1183\/09031936.04.00076904","article-title":"Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis","volume":"24","author":"Bargagli","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2006.01.015_bib46","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1023\/A:1010665807294","article-title":"Crohn\u2019s disease involving the lung","volume":"46","author":"Alrashid","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.amjmed.2006.01.015_bib47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJM200202213460815","article-title":"Tuberculosis and treatment with infliximab","volume":"346","author":"Keane","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJM200202213460815","article-title":"Tuberculosis and treatment with infliximab","volume":"346","author":"Myers","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib49","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00134-003-1867-z","article-title":"Disseminated tuberculosis, pulmonary aspergillosis and cutaneous herpes simplex infection in a patient with infliximab and methotrexate","volume":"29","author":"van der Klooster","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/030097402317255372","article-title":"Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment","volume":"31","author":"Mayordomo","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib51","doi-asserted-by":"crossref","first-page":"xxii","DOI":"10.1016\/S1542-3565(04)00342-8","article-title":"The usefulness of PPD testing in inflammatory bowel disease patients before infliximab therapy","volume":"2","author":"Uthman","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib52","series-title":"Reported Tuberculosis in the United States, 1999","year":"2000"},{"key":"10.1016\/j.amjmed.2006.01.015_bib53","series-title":"Reported Tuberculosis in the United States, 2000","year":"2001"},{"key":"10.1016\/j.amjmed.2006.01.015_bib54","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2006.01.015_bib55","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2006.01.015_bib56","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1086\/424459","article-title":"Reply to Schaible TF","volume":"39","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2006.01.015_bib57","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","article-title":"Invasive pulmonary aspergillosis associated with infliximab therapy","volume":"344","author":"Warris","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJM200202213460815","article-title":"Tuberculosis and treatment with infliximab","volume":"346","author":"Zhang","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9343(01)00945-7","article-title":"Reactivation of histoplasmosis after treatment with infliximab","volume":"112","author":"Nakelchik","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib60","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1378\/chest.124.6.2395","article-title":"Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy","volume":"124","author":"Hage","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2006.01.015_bib61","first-page":"1561","article-title":"Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab","volume":"29","author":"True","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib62","first-page":"267","article-title":"Pulmonary aspergillosis in a patient with rheumatoid arthritis treated by etanercept","volume":"22","author":"Lassoued","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib63","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/art.10082","article-title":"Effect of etanercept on tenosynovitis and nodules in rheumatoid arthritis","volume":"46","author":"Kaiser","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2006.01.015_bib64","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.10096","article-title":"Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept","volume":"46","author":"Kekow","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2006.01.015_bib65","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.10535","article-title":"Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis","volume":"47","author":"Cunnane","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2006.01.015_bib66","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/art.11154","article-title":"Pulmonary rheumatoid nodules in an etanercept-treated patient","volume":"48","author":"Hubscher","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2006.01.015_bib67","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/bmj.329.7477.1266","article-title":"Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab","volume":"329","author":"Ostor","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2006.01.015_bib68","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2006.01.015_bib69","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Green","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2006.01.015_bib70","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.11187","article-title":"Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis","volume":"49","author":"Courtney","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2006.01.015_bib71","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/modpathol.3800333","article-title":"Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy","volume":"18","author":"Yousem","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib72","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/thorax.58.3.278","article-title":"Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy","volume":"58","author":"Vavricka","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2006.01.015_bib73","first-page":"15","article-title":"Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection","volume":"52","author":"Mazurek","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.amjmed.2006.01.015_bib74","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib75","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thorax.57.9.804","article-title":"A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements","volume":"57","author":"Wang","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2006.01.015_bib76","first-page":"81","article-title":"Tuberculosis prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case-control study","volume":"17","author":"Hernandez-Cruz","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.amjmed.2006.01.015_bib77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0002-9343(01)01035-X","article-title":"Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn\u2019s disease after treatment with a tumor necrosis factor-alpha inhibitor","volume":"112","author":"Wagner","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM200107193450307","article-title":"Management of tuberculosis in the United States","volume":"345","author":"Small","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.01.015_bib79","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis","volume":"60","year":"1982","journal-title":"Bull World Health Organ"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934306001537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934306001537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:42:54Z","timestamp":1757580174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934306001537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":79,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0002934306001537"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2006.01.015","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Adverse Events of Anti-Tumor Necrosis Factor-\u03b1 Antibody Therapy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2006.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}